Advertisement
Screener

AirSculpt Technologies, Inc. (AIRS) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

AirSculpt Technologies, Inc. Stock-Based Compensation

AirSculpt Technologies, Inc. (AIRS) reported Stock-Based Compensation of $1.47 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-10

  • AirSculpt Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $912.00K, a 32.54% decline year-over-year.
  • AirSculpt Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $559.00K, a 54.88% decline year-over-year.
  • AirSculpt Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was -$1.39M, a 161.83% decline year-over-year.
  • AirSculpt Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.13M, a 67.20% decline year-over-year.
  • AirSculpt Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $2.33M, a 38.04% decline from fiscal 2024.
  • AirSculpt Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $3.76M, a 79.36% decline from fiscal 2023.
  • AirSculpt Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $18.22M, a 38.13% decline from fiscal 2022.
  • AirSculpt Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $29.46M, a 309.98% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$912.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$1.47M
10-Q · filed 2026-08-10
$86.00K
derived: sum of 3 quarters · filed 2026-08-10
$1.21M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$559.00K
10-Q · filed 2026-05-08
-$826.00K
derived: sum of 2 quarters · filed 2026-05-08
$299.00K
derived: sum of 3 quarters · filed 2026-05-08
$1.65M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$1.39M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06
-$260.00K
derived: sum of 2 quarters · filed 2026-04-06
$1.09M
derived: sum of 3 quarters · filed 2026-08-10
$2.33M
10-K/A · filed 2026-04-06
2025-09-30$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$2.48M
derived: sum of 2 quarters · filed 2026-08-10
$3.72M
10-Q · filed 2025-11-07
$5.96M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30$1.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$2.59M
10-Q · filed 2026-08-10
$4.83M
derived: sum of 3 quarters · filed 2026-08-10
$8.26M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$1.24M
10-Q · filed 2026-05-08
$3.48M
derived: sum of 2 quarters · filed 2026-05-08
$6.91M
derived: sum of 3 quarters · filed 2026-05-08
$11.78M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$2.24M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06
$5.67M
derived: sum of 2 quarters · filed 2026-04-06
$10.54M
derived: sum of 3 quarters · filed 2026-04-06
$3.76M
10-K/A · filed 2026-04-06
2024-09-30$3.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$8.30M
derived: sum of 2 quarters · filed 2025-11-07
$1.52M
10-Q · filed 2025-11-07
$6.26M
derived: sum of 4 quarters · filed 2026-04-06
2024-06-30$4.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01
-$1.91M
10-Q · filed 2025-08-01
$2.83M
derived: sum of 3 quarters · filed 2026-04-06
$7.33M
derived: sum of 4 quarters · filed 2026-04-06
2024-03-31-$6.78M
10-Q · filed 2025-05-02
-$2.04M
derived: sum of 2 quarters · filed 2026-04-06
$2.45M
derived: sum of 3 quarters · filed 2026-04-06
$7.05M
derived: sum of 4 quarters · filed 2026-04-06
2023-12-31$4.74M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06
$9.23M
derived: sum of 2 quarters · filed 2026-04-06
$13.84M
derived: sum of 3 quarters · filed 2026-04-06
$18.22M
10-K/A · filed 2026-04-06
2023-09-30$4.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$9.10M
derived: sum of 2 quarters · filed 2024-11-08
$13.48M
10-Q · filed 2024-11-08
$20.98M
derived: sum of 4 quarters · filed 2025-03-14
2023-06-30$4.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$8.99M
10-Q · filed 2024-08-09
$16.49M
derived: sum of 3 quarters · filed 2025-03-14
$23.86M
derived: sum of 4 quarters · filed 2025-03-14
2023-03-31$4.39M
10-Q · filed 2024-05-10
$11.88M
derived: sum of 2 quarters · filed 2025-03-14
$19.25M
derived: sum of 3 quarters · filed 2025-03-14
$26.53M
derived: sum of 4 quarters · filed 2025-03-14
2022-12-31$7.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
$14.87M
derived: sum of 2 quarters · filed 2025-03-14
$22.14M
derived: sum of 3 quarters · filed 2025-03-14
$29.46M
10-K · filed 2025-03-14
2022-09-30$7.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$14.64M
derived: sum of 2 quarters · filed 2023-11-13
$21.96M
10-Q · filed 2023-11-13
$28.89M
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30$7.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
$14.59M
10-Q · filed 2023-08-11
$21.52M
derived: sum of 3 quarters · filed 2024-02-27
$21.60M
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31$7.32M
10-Q · filed 2023-05-12
$14.24M
derived: sum of 2 quarters · filed 2024-02-27
$14.33M
derived: sum of 3 quarters · filed 2024-02-27
$14.41M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$6.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$7.01M
derived: sum of 2 quarters · filed 2024-02-27
$7.10M
derived: sum of 3 quarters · filed 2024-02-27
$7.18M
10-K · filed 2024-02-27
2021-09-30$86.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$172.00K
derived: sum of 2 quarters · filed 2022-11-14
$258.00K
10-Q · filed 2022-11-14
2021-06-30$86.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$172.00K
10-Q · filed 2022-08-12
2021-03-31$86.00K
10-Q · filed 2022-05-13
2020-12-31$325.00K
10-K · filed 2023-03-10
2019-12-31$341.00K
10-K · filed 2022-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
LifeMD, Inc. (LFMD)United States$0.141B982.53
SBC Medical Group Holdings Inc (SBC)United States$0.487B
Teladoc Health, Inc. (TDOC)United States$1.114B-8.68